StockData
LENSAR, Inc. logo

LENSAR, Inc. (LNSR) stock

LNSRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3022% below fair value
$4.91−0.38 (-7.18%)

Close on Nov 17, 2026Market cap $60.32MP/E –Yield –

Lensar gross margin

Gross margin is gross profit as a percentage of revenue.

Lensar's gross margin for the twelve months ending Jun 30, 2026 was 48.3%. For fiscal 2025 it was 46.4%, against 48.3% the year before. The highest annual figure on record is 56.4% in fiscal 2022.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202546.4%−1.9
FY2024Dec 31, 202448.3%−1.7
FY2023Dec 31, 202350.1%−6.4
FY2022Dec 31, 202256.4%+4.7
FY2021Dec 31, 202151.8%−1.6
FY2020Dec 31, 202053.4%+10.0
FY2019Dec 31, 201943.3%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202659.3%+8.9
Q1 FY2026Mar 31, 202647.5%−2.8
Q4 FY2025Dec 31, 202543.3%+0.8
Q3 FY2025Sep 30, 202542.2%−4.1
Q2 FY2025Jun 30, 202550.4%−3.5
Q1 FY2025Mar 31, 202550.3%−3.2
Q4 FY2024Dec 31, 202442.5%−0.1
Q3 FY2024Sep 30, 202446.3%−3.5
Q2 FY2024Jun 30, 202453.9%−2.4
Q1 FY2024Mar 31, 202453.5%+1.1
Q4 FY2023Dec 31, 202342.5%−20.8
Q3 FY2023Sep 30, 202349.8%−0.4
Q2 FY2023Jun 30, 202356.3%−4.6
Q1 FY2023Mar 31, 202352.4%+2.1
Q4 FY2022Dec 31, 202263.4%+13.2
Q3 FY2022Sep 30, 202250.2%+3.6
Q2 FY2022Jun 30, 202260.9%+4.6
Q1 FY2022Mar 31, 202250.2%−5.1
Q4 FY2021Dec 31, 202150.2%−6.1
Q3 FY2021Sep 30, 202146.6%−8.0
Q2 FY2021Jun 30, 202156.3%+17.7
Q1 FY2021Mar 31, 202155.3%−5.1
Q4 FY2020Dec 31, 202056.3%+1.2
Q3 FY2020Sep 30, 202054.5%+13.9
Q2 FY2020Jun 30, 202038.6%–
Q1 FY2020Mar 31, 202060.4%–
Q4 FY2019Dec 31, 201955.1%–
Q3 FY2019Sep 30, 201940.6%–

More Lensar figures

See a number that looks wrong?